Toggle navigation
HOME
OPERATIONS MANUAL
CODE OF ETHICS FOR AUTHORS
STATEMENT ON THE USE OF AI
CODE OF CONDUCT FOR REVIEWERS
EDITORIAL POLICIES
BROWSE
CURRENT ISSUE
AHEAD OF PRINT
EDITORIAL BOARD
AUTHORS
INSTRUCTIONS
CONTACT
OPEN ACCESS
Paula Cabrera-Galeana
Departamento de OncologÃa Médica de Mama, Instituto Nacional de CancerologÃa, Ciudad de México, México
Diagnóstico y tratamiento del cáncer de mama
HER2
-bajo
Alexandra Garcilazo-Reyes, Claudia H. Arce-Salinas, Alejandro Mohar-Betancourt, Maricela García-Garcés, Paula Cabrera-Galeana
VOLUME 25 - NUMBER 1 /
January - March
Risk factors for the development of hematological toxicity during the application of weekly paclitaxel in breast cancer
Alberto Alvarado-Miranda, Germán Calderillo-Ruiz, Rafael Rodríguez-Ortiz, Lenny Gallardo, Karla Itzel Aguilar-Flores, Paula Cabrera-Galeana
VOLUME 18 - NUMBER 1 /
January-March
Close
